Dow Down 0.17% Nasdaq Down 0.28%

More On CYCCP

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Cyclacel Pharmaceuticals, Inc. (CYCCP)

-NasdaqCM
7.80 Sep 24, 1:00PM EDT
Prev Close:7.80
Open:N/A
Bid:N/A
Ask:9.74 x 700
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:7.16 - 9.70
Volume:0
Avg Vol (3m):478
Market Cap:176.87M
P/E (ttm):N/A
EPS (ttm):-0.97
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):130.05
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cyclacel Pharmaceuticals, Inc., a development-stage biopharmaceutical company, develops and commercializes mechanism-targeted drugs to treat human cancers and other serious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback